5HOC image
Deposition Date 2016-01-19
Release Date 2016-10-19
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5HOC
Keywords:
Title:
p73 homo-tetramerization domain mutant II
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.36 Å
R-Value Free:
0.24
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 42 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tumor protein p73
Gene (Uniprot):TP73
Mutations:E363R, K370E, E373R, R390D
Chain IDs:A, B
Chain Length:50
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Mechanism of TAp73 inhibition by Delta Np63 and structural basis of p63/p73 hetero-tetramerization.
Cell Death Differ. 23 1930 1940 (2016)
PMID: 27716744 DOI: 10.1038/cdd.2016.83

Abstact

Members of the p53 tumor-suppressor family are expressed as multiple isoforms. Isoforms with an N-terminal transactivation domain are transcriptionally active, while those ones lacking this domain often inhibit the transcriptional activity of other family members. In squamous cell carcinomas, the high expression level of ΔNp63α inhibits the tumor-suppressor function of TAp73β. This can in principle be due to blocking of the promoter or by direct interaction between both proteins. p63 and p73 can hetero-oligomerize through their tetramerization domains and a hetero-tetramer consisting of two p63 and two p73 molecules is thermodynamically more stable than both homo-tetramers. Here we show that cells expressing both p63 and p73 exist in mouse epidermis and hair follicle and that hetero-tetramer complexes can be detected by immunoprecipitation in differentiating keratinocytes. Through structure determination of the hetero-tetramer, we reveal why this hetero-tetramer is the thermodynamically preferred species. We have created mutants that exclusively form either hetero-tetramers or homo-tetramers, allowing to investigate the function of these p63/p73 hetero-tetramers. Using these tools, we show that inhibition of TAp73β in squamous cell carcinomas is due to promoter squelching and not direct interaction.

Legend

Protein

Chemical

Disease

Primary Citation of related structures